Vivistim Registry for Paired VNS Therapy (GRASP)

Description

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.

Conditions

Upper Extremity Problem

Study Overview

Study Details

Study overview

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.

Vivistim Registry for Paired VNS Therapy (GRASP)

Vivistim Registry for Paired VNS Therapy (GRASP)

Condition
Upper Extremity Problem
Intervention / Treatment

-

Contacts and Locations

New York

Mt. Sinai, New York, New York, United States, 10029

Philadelphia

Thomas Jefferson, Philadelphia, Pennsylvania, United States, 19107

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients implanted with the Vivistim System for upper limb deficits associated with an ischemic stroke
  • * Not eligible for surgery

Ages Eligible for Study

22 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

MicroTransponder Inc.,

Study Record Dates

2028-12-31